Robert Stott News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The FDA granted accelerated approval to Ipsen Pharma’s Iqirvo 80 mg, a first-in-class oral, once-daily peroxisome proliferator-activated receptor agonist for the treatment of primary biliary cholangitis, according to a company release. Originally given breakthrough therapy designation in 2019, Iqirvo (elafibranor, Ipsen/Genfit), is now indicated as second-line therapy in combination with

The Skoda was being driven by a 75-year-old woman when it came to halt just feet away from staff.

A BRAND new car has ploughed through the window of a shop in a Cheshire town centre.

A YOUNG north Cumbrian farmer caused head-on crash that left two people seriously injured after he “lost concentration.”

CHARLOTTE, N.C. — The CHESS-ALARM score was a better predictor of esophageal varices requiring treatment in patients with cirrhosis vs. other noninvasive criteria, according to data presented at the ACG Annual Scientific Meeting. “During the COVID-19 pandemic, there was a shortage of resources to perform endoscopy procedures, including availability of staff and diversion of resources,